Search Brexit News
NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination
Spravato (pictured), a nasal spray also known as esketamine, got the green light from the European Medicines Agency in December 2019 as a fast-acting treatment for depression sufferers.
* This article was originally published here
A petition to have Blair stripped of his knighthood has snowballed. The petition will soon become one of the most signed, ever a...
ANDREW MARR claimed that the left in Britain faces being "finished" because of their failure to grasp the Brexit result. Re...
A FURIOUS ROW over Brexit erupted on BBC Question Time, as Sir Bernard Jenkin snapped at host Fiona Bruce for repeatedly interrupting hi...